{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T02:07:25Z","timestamp":1768097245475,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,4]]},"DOI":"10.7759\/cureus.16171","type":"journal-article","created":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T17:31:41Z","timestamp":1625419901000},"source":"Crossref","is-referenced-by-count":5,"title":["Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability"],"prefix":"10.7759","author":[{"given":"Nicholas  B","family":"Burley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S","family":"Dy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreyas","family":"Kalantri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanwal","family":"Razzaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization (WHO). Coronavirus disease 2019 (COVID-19). Situation report - 144. (2020). https.\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200612-covid-19-sitrep-144.pdf?sfvrsn=66ff9f...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta A","year":"2020","unstructured":"Gupta A, Madhavan MV, Sehgal K, et al.. Extrapulmonary manifestations of COVID-19. Nat Med. 2020, 26:1017-32. 10.1038\/s41591-020-0968-3","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1709650","article-title":"D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis","volume":"120","author":"Lippi G","year":"2020","unstructured":"Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost. 2020, 120:876-8. 10.1055\/s-0040-1709650","journal-title":"Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry BM","year":"2020","unstructured":"Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020, 58:1021-8. 10.1515\/cclm-2020-0369","journal-title":"Clin Chem Lab Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta P","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020, 395:1033-4. 10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102537","article-title":"Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome","volume":"19","author":"McGonagle D","year":"2020","unstructured":"McGonagle D, Sharif K, O'Regan A, et al.. Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome. Autoimmun Rev. 2020, 19:102537.","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2020.08.087","article-title":"Arterial thrombosis in coronavirus disease 2019 (COVID-19) patients: a rapid systematic review","volume":"70","author":"Cheruiyot I","year":"2021","unstructured":"Cheruiyot I, Kipkorir V, Ngure B, Misiani M, Munguti J, Ogeng'o J. Arterial thrombosis in coronavirus disease 2019 (COVID-19) patients: a rapid systematic review. Ann Vasc Surg. 2021, 70:273-81. 10.1016\/j.avsg.2020.08.087","journal-title":"Ann Vasc Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2450\/2010.0066-10","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"Previtali E","year":"2011","unstructured":"Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus. 2011, 9:120-38. 10.2450\/2010.0066-10","journal-title":"Blood Transfus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31051-5","article-title":"Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19","volume":"395","author":"Perini P","year":"2020","unstructured":"Perini P, Nabulsi B, Massoni CB, Azzarone M, Freyrie A. Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19. Lancet. 2020, 395:1546. 10.1016\/S0140-6736(20)31051-5","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2020.04.483","article-title":"Acute limb ischemia in patients with COVID-19 pneumonia","volume":"72","author":"Bellosta R","year":"2020","unstructured":"Bellosta R, Luzzani L, Natalini G, et al.. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020, 72:1864-72. 10.1016\/j.jvs.2020.04.483","journal-title":"J Vasc Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms J","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, et al.. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020, 46:1089-98. 10.1007\/s00134-020-06062-x","journal-title":"Intensive Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli B","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, et al.. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:2950-73. 10.1016\/j.jacc.2020.04.031","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang N","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020, 18:844-7. 10.1111\/jth.14768","journal-title":"J Thromb Haemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0188","article-title":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection","volume":"58","author":"Han H","year":"2020","unstructured":"Han H, Yang L, Liu R, et al.. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020, 58:1116-20. 10.1515\/cclm-2020-0188","journal-title":"Clin Chem Lab Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease. CHEST Guideline and Expert Panel Report","volume":"149","author":"Kearon C","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, et al.. Antithrombotic therapy for VTE disease. CHEST Guideline and Expert Panel Report. Chest. 2016, 149:315-52. 10.1016\/j.chest.2015.11.026","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2014.10.008","article-title":"Unfractionated heparin attenuates LPS-induced IL-8 secretion via PI3K\/Akt\/NF-\u03baB signaling pathway in human endothelial cells","volume":"220","author":"Li X","year":"2015","unstructured":"Li X, Liu Y, Wang L, Li Z, Ma X. Unfractionated heparin attenuates LPS-induced IL-8 secretion via PI3K\/Akt\/NF-\u03baB signaling pathway in human endothelial cells. Immunobiology. 2015, 220:399-405. 10.1016\/j.imbio.2014.10.008","journal-title":"Immunobiology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/v11040328","article-title":"Canine respiratory coronavirus, bovine coronavirus, and human coronavirus OC43: receptors and attachment factors","volume":"11","author":"Szczepanski A","year":"2019","unstructured":"Szczepanski A, Owczarek K, Bzowska M, et al.. Canine respiratory coronavirus, bovine coronavirus, and human coronavirus OC43: receptors and attachment factors. Viruses. 2019, 11:328. 10.3390\/v11040328","journal-title":"Viruses"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.22.14451-14456.2005","article-title":"Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor","volume":"79","author":"de Haan CA","year":"2005","unstructured":"de Haan CA, Li Z, te Lintelo E, Bosch BJ, Haijema BJ, Rottier PJ. Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J Virol. 2005, 79:14451-6. 10.1128\/JVI.79.22.14451-14456.2005","journal-title":"J Virol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61801-aortic-thrombosis-and-acute-limb-ischemia-secondary-to-covid-hypercoagulability","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:28Z","timestamp":1707507088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61801-aortic-thrombosis-and-acute-limb-ischemia-secondary-to-covid-hypercoagulability"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,4]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.16171","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,4]]}}}